More than 40,000 former Alltel wireless customers in Illinois will see a change as AT&T (NYSE:T) launches service for them. AT&T acquired Alltel´s wireless operations in September 2013. The transaction included subscribers, spectrum and retail and network assets. AT&T, Inc. (NYSE:T) in last trading activity fell -0.18% to close at $33.88. Company weekly performance is -3.37% while its quarterly performance stands at -0.96%. AT&T, Inc. (NYSE:T) is -8.40% away from its 52 week high.
General Motors Company (NYSE:GM) India said it will hike prices of its entire product portfolio by up to Rs 20,000 from next month, in order to partially offset rising input costs. On last trading day General Motors Company (NYSE:GM) fell -3.68% to close at $32.68. Its volatility for the week is 2.16% while volatility for the month is 1.84%. GM’s sales growth for past 5 years was 0.90% and its EPS growth for past 5 years was 15.40%. General Motors Company (NYSE:GM) monthly performance is 4.18%.
Lancaster Colony Corp. (NASDAQ:LANC) declared a quarterly dividend on Tuesday, November 18th, AR Network reports. Shareholders of record on Monday, December 8th will be given a dividend of 0.46 per share on Wednesday, December 31st. This represents a $1.84 dividend on an annualized basis and a yield of 1.94%. On last trading day Lancaster Colony Corporation (NASDAQ:LANC) fell -0.53% to close at $93.73. Its volatility for the week is 1.74% while volatility for the month is 1.70%. LANC’s sales growth for past 5 years was -0.20% and its EPS growth for past 5 years was 3.10%. Lancaster Colony Corporation (NASDAQ:LANC) monthly performance is 2.00%.
Omniamerican Bancorp, Inc. (NASDAQ:OABC) cash dividend payment of $0.05 per share is scheduled to be paid on December 11, 2014. Shareholders who purchased OABC stock prior to the ex-dividend date are eligible for the cash dividend payment. Omniamerican Bancorp, Inc. (NASDAQ:OABC) has 0.80% insider ownership while its institutional ownership stands at 60.70%. In last trading activity company’s stock closed at $26.45.
Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical-stage biopharmaceutical company focused on acute and chronic orphan liver diseases, has appointed Michael Byrnes as chief financial officer. On Monday shares of Ocera Therapeutics, Inc. (NASDAQ:OCRX) closed at $6.28.